Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
Featuring one-on-one discussions with leading clinical investigators, this series bridges the gap between research and patient care by providing practicing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
Built to Lead is a new companion offering that will make the leadership concepts of the Vernissage Health dialogue series accessible to all students in DLSPH and beyond. This series is hosted by Matthew Goulbourne (MHSc Class 2020) and Mobeen Lalani (MHI Class 2023) two emerging health leaders uncovering what it takes to be a great leader in today’s healthcare system. Season 4 of Built to Lead focuses on how health leaders can “challenge the status quo,” act as “good rebels,” and create posi ...
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love with clinical investigators and oncology nurses with expertise in a variety of common cancer types, this series provides practicing clinicians, including nurses and nurse practitioners, with practical information and valuable perspectives that can be applied to optimize patient care.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ovarian and Endometrial Cancer | Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52:23
52:23
Spill senere
Spill senere
Lister
Lik
Likt
52:23
Featuring an interview with Dr Angeles Alvarez Secord, including the following topics: Front-line management of ovarian cancer (0:00) Management of relapsed/refractory ovarian cancer (20:06) Management of microsatellite instability-high/mismatch repair-deficient endometrial cancer (23:20) Management of microsatellite stable/mismatch repair-proficie…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52:36
52:36
Spill senere
Spill senere
Lister
Lik
Likt
52:36
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers.Av Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52:36
52:36
Spill senere
Spill senere
Lister
Lik
Likt
52:36
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Non-Small Cell Lung Cancer | Professor Solange Peters, MD, PhD
39:01
39:01
Spill senere
Spill senere
Lister
Lik
Likt
39:01
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer | Faculty Presentation 1: Significance of Biomarker Testing in Localized Non-Small Cell Lung Cancer (NSCLC) and Historical Management Paradigm for ALK-Positive Disease — Professor Solange Peters, MD, PhD CME information and select publicat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Non-Small Cell Lung Cancer | Professor Ben Solomon, MBBS, PhD
21:43
21:43
Spill senere
Spill senere
Lister
Lik
Likt
21:43
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer | Faculty Presentation 2: Emerging Role and Practical Application of ALK-Targeted Therapy in Localized NSCLC — Professor Ben Solomon, MBBS, PhD CME information and select publicationsAv Dr. Neil Love
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Non-Small Cell Lung Cancer | Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:24
1:01:24
Spill senere
Spill senere
Lister
Lik
Likt
1:01:24
Featuring perspectives from Prof Solange Peters and Prof Ben Solomon, including the following topics: Introduction (0:00) Significance of Biomarker Testing in Localized Non-Small Cell Lung Cancer (NSCLC) and Historical Management Paradigm for ALK-Positive Disease — Prof Peters (9:17) Emerging Role and Practical Application of ALK-Targeted Therapy i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
1:01:23
1:01:23
Spill senere
Spill senere
Lister
Lik
Likt
1:01:23
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting, moderated by Dr Neil Love. Produced by Research To Practice. CME in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Breast Cancer | Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:03
54:03
Spill senere
Spill senere
Lister
Lik
Likt
54:03
Featuring perspectives from Dr Sara A Hurvitz, including the following topics: Case: A woman in her late 40s who received treatment for triple-negative breast cancer develops lung metastases 2 years later (0:00) Clinical trials investigating TROP2-targeting antibody-drug conjugates (13:28) Identifying and targeting HER2 in HER2 low-expressing disea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:17
54:17
Spill senere
Spill senere
Lister
Lik
Likt
54:17
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting
22:50
22:50
Spill senere
Spill senere
Lister
Lik
Likt
22:50
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting
22:50
22:50
Spill senere
Spill senere
Lister
Lik
Likt
22:50
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Lung Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
1:01:44
1:01:44
Spill senere
Spill senere
Lister
Lik
Likt
1:01:44
Featuring perspectives from Dr Melissa Johnson, Dr Ticiana Leal and Dr Manish Patel, including the following topics: Introduction: Two Faces of Lung Cancer Research (0:00) B7-H3-Targeted Antibody-Drug Conjugates for Lung Cancer — Dr Patel (16:14) Potential Role of Tumor Treating Fields in the Management of Metastatic Non-Small Cell Lung Cancer — Dr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Novel Agents and Strategies in Lung Cancer
1:01:43
1:01:43
Spill senere
Spill senere
Lister
Lik
Likt
1:01:43
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Myeloma | Jesús G Berdeja, MD
1:00:33
1:00:33
Spill senere
Spill senere
Lister
Lik
Likt
1:00:33
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates for MM — Jesús G Berdeja, MD CME information and select publications…
…
continue reading
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 1: Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Thomas Martin, MD CME information and select publicationsAv Dr. Neil Love
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:04
1:02:04
Spill senere
Spill senere
Lister
Lik
Likt
1:02:04
Featuring perspectives from Dr Jesús G Berdeja and Dr Thomas Martin, including the following topics: Introduction: Real-World Regulatory Issues in Multiple Myeloma (MM) (0:00) Newly Diagnosed MM (14:30) Novel Agents for Relapsed/Refractory MM (24:58) Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies (44:28) CME information and sele…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Skin Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
59:36
59:36
Spill senere
Spill senere
Lister
Lik
Likt
59:36
Featuring perspectives from Dr Evan J Lipson, including the following topics: Introduction: Johns Hopkins University (0:00) Metastatic Melanoma (8:21) Nonmetastatic Melanoma and Other Skin Cancers (34:20) CME information and select publicationsAv Dr. Neil Love
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:03
1:02:03
Spill senere
Spill senere
Lister
Lik
Likt
1:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and s…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
59:35
59:35
Spill senere
Spill senere
Lister
Lik
Likt
59:35
Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Av Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Breast Cancer | Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
1:14:37
1:14:37
Spill senere
Spill senere
Lister
Lik
Likt
1:14:37
Featuring an interview with Dr Joyce O’Shaughnessy, including the following topics: Overview of CDK Inhibition for Metastatic Breast Cancer (0:00) Features of High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (7:45) Sequencing and Selection of CDK4/6 Inhibitors (23:28) Management of Toxicities Associated with CDK Inhibitors and Promotin…
…
continue reading